Knockdown experiments showed that silencing YY1 led to a significant decrease in both CXCL1 mRNA and secreted protein levels in CRC cells, whereas silencing TCF7L2 had no significant effect (Figure S6F–H, Supporting Information). Here, TCF7L2 is linked to colorectal carcinoma.